RESIST ACINETO test for the rapid detection of NDM and OXA acquired carbapenemases directly from blood culture in Acinetobacter species

• Published in: Microbiology spectrum p. e0104424
• Main Authors: Potron, Anaïs, Daniel, Marion, Bay, Mila, Choulet, Pauline, Garrigos, Thomas, Sababadichetty, Loïk, Belmonte, Olivier, Fournier, Damien, Jeannot, Katy, Miltgen, Guillaume
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 20.08.2024
• Subjects: Applied and Industrial Microbiology; Observation; OXA-23; NDM; Acinetobacter; OXA-24/40; rapid detection; carbapenemases; OXA-58; blood culture
• ISSN: 2165-0497; 2165-0497
• DOI: 10.1128/spectrum.01044-24

Carbapenem-resistant (CRAB) are increasingly reported worldwide and a leading cause of mortality associated with antimicrobial resistance. Their early detection, particularly in the cases of bloodstream infections, is crucial in attempting to initiate effective antibiotic treatment. The immunochromatographic assay RESIST ACINETO (Coris BioConcept) is a new test developed for the detection of OXA-23, OXA-40/58, and New-Delhi Metallo-beta-lactamase (NDM) carbapenemases in spp. We evaluated this test on a collection of 121 spp. clinical isolates, including 104 carbapenemase producers (97 carbapenemases targeted by the test) and 17 non-carbapenemase producers. The performance of the RESIST ACINETO test was evaluated according to the manufacturer's recommendations from bacterial and blood cultures. The strains producing the carbapenemases OXA-23, -40, -58, or/and NDM were accurately detected from bacterial cultures and directly from blood cultures, with the exception of one OXA-23/NDM-1-positive isolate (only detected through standard culture). None of the non-carbapenemase producers tested positive. The RESIST ACINETO test demonstrated sensitivity/specificity of 100%/100% and 99%/100% on bacterial and blood cultures, respectively. The incidence of bloodstream infections with carbapenem-resistant (CRAB) could be very high in some countries such as the Balkans or Southeast Asia. In case of positive blood cultures with Gram-negative bacteria, the use of the RESIST ACINETO test could prove highly beneficial for the rapid identification of these imipenem-resistant bacteria and their antibiotic resistance mechanisms. In addition, it is now well established that New-Delhi Metallo-beta-lactamase (NDM) carbapenemase-producing isolates can have increased MICs of cefiderocol, which is an alternative treatment for these infections. This test may also allow the optimization of treatment based on the type of carbapenemase present. Finally, the RESIST ACINETO test is a rapid, easy-to-use, and cost-effective assay that demonstrates excellent performance in detecting the major acquired carbapenemases present in the .